Opexa Therapeutics, Inc. (OPXA)

[redspinelpinktopaz]

To any and all: go into "seeking alpha" and put in OPXA and read the comments, especially the longish one, yesterday, from "ATLnsider". He seems to know what he's talking about and, among other things, points out that reduction in "brain volume loss, is the 37.5%, that we've all heard of, from Neil. But it is only 17.5% for Roche's Ocrelizumab, a monoclonal antibody, which of course is a lot different than an irradiated T cell.